Copper Deficiency Myelopathy Treatment Guidelines

Introduction to Copper Deficiency Treatment

The American College of Nutrition recommends initiating treatment with 4-8 mg of copper daily for copper deficiency myelopathy, which is substantially higher than standard supplementation doses, and consider intravenous administration in severe cases or when oral therapy fails to restore levels 1

For severe copper deficiency (plasma copper <8 μmol/L), repletion measures must be taken immediately, regardless of CRP elevation, with a therapeutic dose of 4-8 mg copper daily 1, 2
The route of administration should be determined by the severity of the deficit, with intravenous copper repletion considered for rapid correction in cases of myelopathy with severe neurological symptoms 1

Always check both zinc and copper levels simultaneously when considering copper replacement, as high zinc is a common cause of copper deficiency, and maintain a ratio of 8-15 mg zinc to 1 mg copper when supplementing both minerals 3, 4
Copper status must be determined by measuring plasma copper simultaneously with CRP, as inflammation falsely elevates copper levels 1, 2

Copper levels should be measured in all patients following bariatric surgery or other abdominal surgeries that exclude the duodenum, and with severe copper deficiency in this population, refer for specialist advice 1, 2, 3, 4
Standard post-bariatric supplementation provides only 1-3 mg copper daily, which is insufficient for treating established deficiency 1, 5

Do not use standard supplementation doses (1-3 mg daily) to treat established deficiency—these are prophylactic doses only 1, 5
Do not supplement copper without checking zinc levels first, as the interaction between these minerals is bidirectional 3, 4
Do not assume normal copper levels if CRP is elevated, as ceruloplasmin (which carries copper) is an acute phase reactant 1, 2
Do not delay treatment waiting for specialist referral in severe cases—initiate copper replacement immediately while arranging follow-up 3, 4

Copper deficiency primarily presents with hematologic abnormalities and myeloneuropathy, with neurological symptoms often being irreversible if treatment is delayed, according to the Advances in Nutrition guidelines 6
Impaired wound healing is a manifestation of copper deficiency, as reported in Advances in Nutrition 6
Routine monitoring should be performed in patients after malabsorptive bariatric procedures, particularly gastric bypass surgery, as this has become the most frequent cause of severe acquired copper deficiency, as stated in Advances in Nutrition 6
Patients following Roux-en-Y gastric bypass or other bariatric procedures are at risk of copper deficiency, as noted in Advances in Nutrition 6
Patients with persistent diarrhea are at risk of copper deficiency, according to Advances in Nutrition 6
Patients with unexplained anemia, neutropenia, or myeloneuropathy should be evaluated for copper deficiency, as recommended in Advances in Nutrition 6

Copper levels should be evaluated only in symptomatic patients or those with specific risk factors, such as malabsorptive bariatric procedures, as stated in Advances in Nutrition 6
Severe copper deficiency is defined as plasma copper <8 μmol/L, although this value may not be accurate in the presence of inflammation, as reported in Advances in Nutrition 6
For copper deficiency myelopathy, treatment with 4-8 mg of copper daily is recommended, which is substantially higher than standard supplementation doses, although the exact dosing is not specified in the provided citations 6